Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VOR
VOR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VOR News
Biotech Sector Sees Surge in FDA and Global Approvals
6d ago
NASDAQ.COM
China Approves First Therapy for Sjögren's Disease
Jun 08 2026
Newsfilter
Vor Bio Grants Stock Options and RSUs to New Employees
Jun 01 2026
Newsfilter
FCPM III Reduces Stake in Dyne Therapeutics by $14 Million
May 30 2026
Yahoo Finance
Vor Biopharma Reports Significant Increase in Q1 Net Loss
May 13 2026
seekingalpha
Vor Bio Reports Q1 2026 Financial Results and Updates on Telitacicept Trials
May 13 2026
Newsfilter
Vor Biopharma Reports Q4 2025 Net Income Surge
Mar 30 2026
seekingalpha
Latest Wall Street Rating Updates
Mar 30 2026
CNBC
RPT-VOR BIOPHARMA REPORTS Q4 NET INCOME OF USD 1,722.8 MILLION, SURPASSING IBES ESTIMATE OF USD -28.9 MILLION
Mar 30 2026
moomoo
VOR Biopharma Inc: Jefferies Begins Coverage with a Buy Rating and Sets Target Price at $50
Mar 30 2026
moomoo
VOR Biopharma Stock Increases by 1.5% Following $75 Million Private Placement
Mar 27 2026
moomoo
Vor Bio Secures $75M in Private Placement Financing
Mar 27 2026
seekingalpha
Vor Bio Secures $75 Million in Private Placement Financing
Mar 27 2026
Newsfilter
Vor Biopharma Appoints Two New Board Members to Support $150M PIPE Financing
Dec 23 2025
Globenewswire
Vor Bio Secures $150 Million in Private Placement at $10.81 per Share
Dec 15 2025
Newsfilter
J.P. Morgan Initiates Coverage on Lead Asset with Overweight Rating, Boosting Bio Shares
Dec 09 2025
SeekingAlpha
Show More News
